Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue Suppl 3
256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699)
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and young investigator award abstracts
Checkpoint blockade therapy
256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699)
Online download statistics by month:
Online download statistics by month: November 2020 to June 2025
Abstract
Full
Pdf
Nov 2020
212
0
11
Dec 2020
66
0
27
Jan 2021
64
0
5
Feb 2021
48
0
3
Mar 2021
44
0
4
Apr 2021
40
0
3
May 2021
4
0
5
Jun 2021
0
0
2
Jul 2021
0
0
5
Aug 2021
0
0
2
Sep 2021
0
0
3
Oct 2021
34
0
24
Nov 2021
30
0
16
Dec 2021
16
0
2
Jan 2022
28
0
1
Feb 2022
14
0
4
Mar 2022
12
0
5
Apr 2022
36
0
3
May 2022
38
0
1
Jun 2022
16
0
1
Jul 2022
18
0
0
Aug 2022
30
0
4
Sep 2022
24
0
3
Oct 2022
18
0
2
Nov 2022
22
0
4
Dec 2022
32
0
3
Jan 2023
18
0
0
Feb 2023
26
0
0
Mar 2023
24
0
0
Apr 2023
22
0
9
May 2023
26
0
0
Jun 2023
22
0
3
Jul 2023
34
0
1
Aug 2023
38
0
5
Sep 2023
18
0
1
Oct 2023
42
0
4
Nov 2023
50
0
5
Dec 2023
34
0
0
Jan 2024
28
0
0
Feb 2024
30
0
1
Mar 2024
34
0
2
Apr 2024
28
0
1
May 2024
62
0
2
Jun 2024
44
0
0
Jul 2024
20
0
1
Aug 2024
36
0
1
Sep 2024
22
0
1
Oct 2024
20
0
3
Nov 2024
22
0
3
Dec 2024
44
0
12
Jan 2025
24
0
5
Feb 2025
16
0
6
Mar 2025
0
0
1
Apr 2025
0
0
5
May 2025
0
0
3
Jun 2025
0
0
4
Total
1630
0
222
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?